{"id":991394,"date":"2026-08-06T13:31:12","date_gmt":"2026-08-06T17:31:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/"},"modified":"2026-08-06T13:31:12","modified_gmt":"2026-08-06T17:31:12","slug":"seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/","title":{"rendered":"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>DENVER, Aug.  06, 2026  (GLOBE NEWSWIRE) &#8212; SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its second quarter financial results after market close on Wednesday, August 12, 2026, and host a webcast and conference call to discuss its financial results and business progress.<\/p>\n<table style=\"border-collapse: collapse;width:99%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%\">Date\/Time:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%\">Wednesday, August 12, 2026, at 4:30 p.m. ET \/ 2:30 p.m. MT<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>The live webcast and replay can be found <a href=\"https:\/\/investors.seastarmedical.com\/events-and-presentations\/default.aspx\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/td>\n<\/tr>\n<tr>\n<td>Register for the call:<\/td>\n<td>Preregistration is required to attend the live call and can be accessed <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/nuea5sz9\" rel=\"nofollow\" target=\"_blank\">here<\/a>. A pin code and dial in number will be provided with registration.<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\">A replay of the call will be available after 7:30 p.m. ET and can be accessed <a href=\"https:\/\/investors.seastarmedical.com\/events-and-presentations\/default.aspx\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About SeaStar Medical<\/strong>\n      <\/p>\n<p>SeaStar Medical is a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life. SeaStar Medical\u2019s first commercial product,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dzXt1mLhEsljSN48714t5b7vLjsDGllMU71SFiJezCJMo5u0IM37cPj6NAXcPBAToCkXTwesJsLZQZ_02M3f9O1L_we4Dn-lsZUvDyM0jqRhsDJRiEsaLJVkL_5EW_THPs4Ypd79IeIEkNkjgjRh_cEvhnA9yi6DF2GTCunCGK2CW8Cny7G0xfuaxzvfidhJAPk68EDkn42eBke0dHgkqE6UY9xuXN_7PgZqw-L2dwMITXi5h5AMpdtA_eniCZJ5I3cdr3dj2x-fbKkOFfo6uXooBaWYhbsOO8WDOa6djWA=\" rel=\"nofollow\" target=\"_blank\"><u>QUELIMMUNE (SCD-PED)<\/u><\/a>, was approved in 2024 by the U.S. Food and Drug Administration (FDA). It is the only FDA approved product for the ultra-rare condition of life-threatening Acute Kidney Injury (AKI) due to sepsis or a septic condition requiring renal replacement therapy (RRT) in critically ill pediatric patients. SeaStar Medical\u2019s Selective Cytopheretic Device (SCD) therapy has been awarded Breakthrough Device Designation for six therapeutic indications by the FDA, enabling the potential for a speedier pathway to approval and preferable reimbursement dynamics at commercial launch. The company is currently conducting the NEUTRALIZE-AKI pivotal clinical trial of its SCD therapy in adult patients with AKI requiring continuous renal replacement therapy, a life-threatening condition with no effective treatment options that impacts over 200,000 adults in the U.S. annually.<\/p>\n<p>For more information visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mzjDuyRsfSBYB_k7f9ee1BrBNFzgpld8Myv2ioxXPpWqsTRCiI4Jj3cDYdeyTmUhk8DfWLnfX9sE761jlOKz1waMRMHMjQFs5OlvioB-t0xjGgmUfNUEq41V44Z93xuENaphlvl9yUYuqFkFbK60SHB7uOzdJsYgqrxlhYN43rpAyLSuGk4u9qY1vpZj01V4WJNO-L7zMON1A1-gUCM5RV8T7s36lLoCBODJcTn7eMEJodkERnsaF3ppsp6gvicz7ZZfKQz-RPj0dkEUIxF-1Q==\" rel=\"nofollow\" target=\"_blank\"><u>www.seastarmedical.com<\/u><\/a>\u00a0or visit us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S2XufHmKBng1YSMvbwVobuB0zomUawtQIRqpQ4Hr0Gv_lj1gZAFRo5rlz3sdVk2E1E1pD4cW14JUzhT22y4phIdthYuSDbytsb1zZNGJbddsxdcagVJg7mqAoQ47Ks_aevMK-le1Sdf1hzn1XelGtVQwE-ihkOF4rf1tVnH_nuNH750VZdK6CAbCQSFE6Aa-m6T0wItoZkkZ6daKiJ0f7eE9QlGtBj61Yi8SeUMvmcqfJEG_ZLgKAYOA5iYWa7JzlXUW99KCSKQTAkF2pmI93w==\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>\u00a0or\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_Qp19d12iLCB6uL1P4L0bhNxf8MNiXRcC0pCZgKfbWLWv9mGmhjUVE8B_xMNvHgzh_XIwS6JXiEe-KLZC1ytKhwYsAlndnLN6_V0dt0hHR3Eop1Wd7m8oFKhterrhtV19wOyx69cMznYD6Xh8qplZ7k3qiespYQQEQ3D9ZaWl_FVJElINPUY6Qz00B5JZMtnpmnqhd22GOTtFnoRVMU98g==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong><br \/>\n        <br \/>SeaStar Investor Relations: <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_ja65lOWhqEYH7AvCwCMfRGYJkTuVHSC5g4Df2JSPkWePQUDDZ5MxiUk_yXx_dMnugvRJOE3OXMpv4uvn5QRManmGfjdzjU-NEpkA1-C2jI=\" rel=\"nofollow\" target=\"_blank\">IR@SeaStarMed.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTRkZmNlZWEtZGQyOC00MzA0LWFkMjYtY2E4ZGM2OWMyMjg4LTEzMTEwODMtMjAyNi0wOC0wNi1lbg==\/tiny\/SeaStar-Medical.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its second quarter financial results after market close on Wednesday, August 12, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date\/Time: Wednesday, August 12, 2026, at 4:30 p.m. ET \/ 2:30 p.m. MT Webcast: The live webcast and replay can be found here. Register for the call: Preregistration is required to attend the live call and can be accessed here. A pin code and dial in number will be provided with registration. \u00a0 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-991394","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its second quarter financial results after market close on Wednesday, August 12, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date\/Time: Wednesday, August 12, 2026, at 4:30 p.m. ET \/ 2:30 p.m. MT Webcast: The live webcast and replay can be found here. Register for the call: Preregistration is required to attend the live call and can be accessed here. A pin code and dial in number will be provided with registration. \u00a0 &hellip; Continue reading &quot;SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-06T17:31:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026\",\"datePublished\":\"2026-08-06T17:31:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/\",\"name\":\"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=\",\"datePublished\":\"2026-08-06T17:31:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Market Newsdesk","og_description":"DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) &#8212; SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its second quarter financial results after market close on Wednesday, August 12, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date\/Time: Wednesday, August 12, 2026, at 4:30 p.m. ET \/ 2:30 p.m. MT Webcast: The live webcast and replay can be found here. Register for the call: Preregistration is required to attend the live call and can be accessed here. A pin code and dial in number will be provided with registration. \u00a0 &hellip; Continue reading \"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-06T17:31:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026","datePublished":"2026-08-06T17:31:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/","name":"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=","datePublished":"2026-08-06T17:31:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDkxNCM3NzYyMTQ5IzIyOTk1MzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/seastar-medical-to-report-second-quarter-financial-results-on-august-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/991394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=991394"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/991394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=991394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=991394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=991394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}